Novartis AGNVS

Where NVS's Net Debt / EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$137.16-0.32 (-0.23%)Previous close
NYSEHealthcare

NVS Net Debt / EBITDA: current value, 10-year range and year-by-year history

Net Debt / EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
NVS Net Debt / EBITDA historyNVS Net Debt / EBITDA from Sep 2023 to Jun 2026: low 0.71, high 1.86, latest 1.86.0.620.951.281.621.95Sep 23Mar 24Sep 24Jun 25Dec 25Jun 26med 0.98

NVS Net Debt / EBITDA by year

Yearly range of NVS’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from 0.5 to 2.0, averaging 1.3.

NVS Net Debt / EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
20261.81.81.91.9
20251.01.11.11.1
20240.91.01.11.0
20230.70.91.10.7
20220.50.81.31.3
20210.61.42.00.6
20201.61.82.01.6
20191.11.31.41.2
20180.81.22.00.9
20171.51.82.01.5
20161.21.31.41.2

Get notified when NVS Net Debt / EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.

Formula(Total Debt − Cash) / EBITDA
Full guide
How to read this chart

Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.

Key caveats
  • Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
  • Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.